Top

Published in:

01-08-2018

Diagnosis of Budd–Chiari syndrome

Authors: Morgane Van Wettere, Onorina Bruno, Pierre-Emmanuel Rautou, Valérie Vilgrain, Maxime Ronot

Published in: Abdominal Radiology | Issue 8/2018

Abstract

Budd–Chiari syndrome (BCS) is defined by clinical and laboratory signs associated with partial or complete impairment of hepatic venous drainage in the absence of right heart failure or constrictive pericarditis. Primary BCS is the most frequent type and is a complication of hypercoagulable states, in particular myeloproliferative neoplasms. Secondary BCS involves tumor invasion or extrinsic compression. Most patients present with chronic BCS including a non-cirrhotic, dysmorphic, chronic liver disease with various degrees of fibrosis deposition. Acute BCS is rare, and patients present with hepatomegaly, ascites, and hepatic insufficiency. The diagnosis is based on imaging. Imaging features include (1) direct signs, in particular occlusion or compression of the hepatic veins and/or the inferior vena cava and venous collaterals and (2) indirect signs, in particular morphological changes in the liver with hypertrophy of the caudate lobe and delayed nodule formation. Ultrasound and magnetic resonance imaging are the gold standard for diagnosis. The aim of this review is to provide an overview of the role of imaging in the diagnosis of BCS.

Aydinli M, Bayraktar Y (2007) Budd–Chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol 13(19):2693–2696CrossRefPubMedPubMedCentral

European Association for the Study of the Liver. Electronic address eee (2016) EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol 64(1):179–202. https://doi.org/10.1016/j.jhep.2015.07.040 CrossRef

Valla DC (2003) The diagnosis and management of the Budd–Chiari syndrome: consensus and controversies. Hepatology 38(4):793–803. https://doi.org/10.1053/jhep.2003.50415 CrossRefPubMed

Langlet P, Escolano S, Valla D, et al. (2003) Clinicopathological forms and prognostic index in Budd–Chiari syndrome. J Hepatol 39(4):496–501CrossRefPubMed

Valla DC (2009) Primary Budd–Chiari syndrome. J Hepatol 50(1):195–203. https://doi.org/10.1016/j.jhep.2008.10.007 CrossRefPubMed

Valla D, Benhamou JP (1996) Obstruction of the hepatic veins or suprahepatic inferior vena cava. Dig Dis 14(2):99–118CrossRefPubMed

Valla D, Dhumeaux D, Babany G, et al. (1987) Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd–Chiari syndrome. Gastroenterology 93(3):569–575CrossRefPubMed

Myones BL, McCurdy D (2000) The antiphospholipid syndrome: immunologic and clinical aspects. Clinical spectrum and treatment. J Rheumatol Suppl 58:20–28PubMed

Deltenre P, Denninger MH, Hillaire S, et al. (2001) Factor V Leiden related Budd–Chiari syndrome. Gut 48(2):264–268CrossRefPubMedPubMedCentral

10.

Denninger MH, Beldjord K, Durand F, et al. (1995) Budd–Chiari syndrome and factor V Leiden mutation. Lancet 345(8948):525–526CrossRefPubMed

11.

Janssen HL, Meinardi JR, Vleggaar FP, et al. (2000) Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd–Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 96(7):2364–2368PubMed

12.

Denninger MH, Chait Y, Casadevall N, et al. (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31(3):587–591. https://doi.org/10.1002/hep.510310307 CrossRefPubMed

13.

Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M (1997) Budd–Chiari syndrome: a common complication of Behcet’s disease. Am J Gastroenterol 92(5):858–862PubMed

14.

Bismuth E, Hadengue A, Hammel P, Benhamou JP (1990) Hepatic vein thrombosis in Behcet’s disease. Hepatology 11(6):969–974CrossRefPubMed

15.

Qi X, Han G, Guo X, et al. (2016) Review article: the aetiology of primary Budd–Chiari syndrome—differences between the West and China. Aliment Pharmacol Ther 44(11–12):1152–1167. https://doi.org/10.1111/apt.13815 CrossRefPubMed

16.

Gowda RM, Gowda MR, Mehta NJ, et al. (2004) Right atrial extension of primary venous leiomyosarcoma: pulmonary embolism and Budd–Chiari syndrome at presentation-a case report. Angiology 55(2):213–216. https://doi.org/10.1177/000331970405500215 CrossRefPubMed

17.

Schraut WH, Chilcote RR (1985) Metastatic Wilms’ tumor causing acute hepatic-vein occlusion (Budd–Chiari syndrome). Gastroenterology 88(2):576–579CrossRefPubMed

18.

Taylor RW, Sylwestrowicz T, Kossakowska AE, Urbanski SJ, Minuk GY (1987) Leiomyosarcoma of the inferior vena cava presenting as Budd–Chiari syndrome. Liver 7(4):201–205CrossRefPubMed

19.

Thapar PM, Mathur SK, Saksena DS, Shah HK (2001) Leiomyosarcoma of inferior vein cava presenting as acute Budd–Chiari syndrome. Indian J Gastroenterol 20(1):33–35PubMed

20.

Hadengue A, Poliquin M, Vilgrain V, et al. (1994) The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 106(4):1042–1047CrossRefPubMed

21.

Brancatelli G, Vilgrain V, Federle MP, et al. (2007) Budd–Chiari syndrome: spectrum of imaging findings. AJR Am J Roentgenol 188(2):W168–176. https://doi.org/10.2214/AJR.05.0168 CrossRefPubMed

22.

Copelan A, Remer EM, Sands M, Nghiem H, Kapoor B (2015) Diagnosis and management of Budd Chiari syndrome: an update. Cardiovasc Intervent Radiol 38(1):1–12. https://doi.org/10.1007/s00270-014-0919-9 CrossRefPubMed

23.

Cura M, Haskal Z, Lopera J (2009) Diagnostic and interventional radiology for Budd–Chiari syndrome. Radiographics 29(3):669–681. https://doi.org/10.1148/rg.293085056 CrossRefPubMed

24.

Ferral H, Behrens G, Lopera J (2012) Budd–Chiari syndrome. AJR Am J Roentgenol 199(4):737–745. https://doi.org/10.2214/AJR.12.9098 CrossRefPubMed

25.

Kamath PS (2006) Budd–Chiari syndrome: radiologic findings. Liver Transpl 12(11 Suppl 2):S21–22. https://doi.org/10.1002/lt.20939 CrossRefPubMed

26.

Patil P, Deshmukh H, Popat B, Rathod K (2012) Spectrum of imaging in Budd Chiari syndrome. J Med Imaging Radiat Oncol 56(1):75–83. https://doi.org/10.1111/j.1754-9485.2012.02341.x CrossRefPubMed

27.

Cheng D, Xu H, Hua R, et al. (2015) Comparative study of MRI manifestations of acute and chronic Budd–Chiari syndrome. Abdom Imaging 40(1):76–84. https://doi.org/10.1007/s00261-014-0193-y CrossRefPubMed

28.

Seijo S, Reverter E, Miquel R, et al. (2012) Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig Liver Dis 44(10):855–860. https://doi.org/10.1016/j.dld.2012.05.005 CrossRefPubMed

29.

Millener P, Grant EG, Rose S, et al. (1993) Color Doppler imaging findings in patients with Budd–Chiari syndrome: correlation with venographic findings. AJR Am J Roentgenol 161(2):307–312. https://doi.org/10.2214/ajr.161.2.8333368 CrossRefPubMed

30.

Ralls PW, Johnson MB, Radin DR, et al. (1992) Budd–Chiari syndrome: detection with color Doppler sonography. AJR Am J Roentgenol 159(1):113–116. https://doi.org/10.2214/ajr.159.1.1609684 CrossRefPubMed

31.

Bargallo X, Gilabert R, Nicolau C, et al. (2006) Sonography of Budd–Chiari syndrome. AJR Am J Roentgenol 187(1):W33–41. https://doi.org/10.2214/AJR.04.0918 CrossRefPubMed

32.

Bargallo X, Gilabert R, Nicolau C, et al. (2003) Sonography of the caudate vein: value in diagnosing Budd–Chiari syndrome. AJR Am J Roentgenol 181(6):1641–1645. https://doi.org/10.2214/ajr.181.6.1811641 CrossRefPubMed

33.

Darwish Murad S, Valla DC, de Groen PC, et al. (2006) Pathogenesis and treatment of Budd–Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 101(1):83–90. https://doi.org/10.1111/j.1572-0241.2006.00353.x CrossRefPubMed

34.

Vogelzang RL, Anschuetz SL, Gore RM (1987) Budd–Chiari syndrome: CT observations. Radiology 163(2):329–333. https://doi.org/10.1148/radiology.163.2.3562813 CrossRefPubMed

35.

Cho OK, Koo JH, Kim YS, et al. (1996) Collateral pathways in Budd–Chiari syndrome: CT and venographic correlation. AJR Am J Roentgenol 167(5):1163–1167. https://doi.org/10.2214/ajr.167.5.8911174 CrossRefPubMed

36.

Ronot M, Kerbaol A, Rautou PE, et al. (2015) Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver. Eur Radiol . https://doi.org/10.1007/s00330-015-4124-2 CrossRefPubMed

37.

Perarnau JM, Bacq Y (2008) Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy. Semin Liver Dis 28(3):315–327. https://doi.org/10.1055/s-0028-1085099 CrossRefPubMed

38.

Mathieu D, Vasile N, Menu Y, et al. (1987) Budd–Chiari syndrome: dynamic CT. Radiology 165(2):409–413. https://doi.org/10.1148/radiology.165.2.3659365 CrossRefPubMed

39.

Erden A, Erden I, Karayalcin S, Yurdaydin C (2002) Budd–Chiari syndrome: evaluation with multiphase contrast-enhanced three-dimensional MR angiography. AJR Am J Roentgenol 179(5):1287–1292. https://doi.org/10.2214/ajr.179.5.1791287 CrossRefPubMed

40.

Noone TC, Semelka RC, Siegelman ES, et al. (2000) Budd–Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging 11(1):44–50CrossRefPubMed

41.

Soyer P, Rabenandrasana A, Barge J, et al. (1994) MRI of Budd–Chiari syndrome. Abdom Imaging 19(4):325–329CrossRefPubMed

42.

Wang Q, Han G. (2017) Image-guided treatment of Budd–Chiari syndrome: a giant leap from the past, a small step towards the future. Abdom Radiol. https://doi.org/10.1007/s00261-017-1341-y CrossRef

43.

Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R (2002) Benign regenerative nodules in Budd–Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics 22(4):847–862. https://doi.org/10.1148/radiographics.22.4.g02jl17847 CrossRefPubMed

44.

Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R (2002) Large regenerative nodules in Budd–Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol 178(4):877–883. https://doi.org/10.2214/ajr.178.4.1780877 CrossRefPubMed

45.

de Sousa JM, Portmann B, Williams R (1991) Nodular regenerative hyperplasia of the liver and the Budd–Chiari syndrome. Case report, review of the literature and reappraisal of pathogenesis. J Hepatol 12(1):28–35CrossRefPubMed

46.

Moucari R, Rautou PE, Cazals-Hatem D, et al. (2008) Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors. Gut 57(6):828–835. https://doi.org/10.1136/gut.2007.139477 CrossRefPubMed

47.

Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd–Chiari syndrome: imaging features. Radiology 210(2):443–450. https://doi.org/10.1148/radiology.210.2.r99fe13443 CrossRefPubMed

48.

Choi JY, Lee HC, Yim JH, et al. (2011) Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. J Gastroenterol Hepatol 26(6):1004–1009. https://doi.org/10.1111/j.1440-1746.2011.06659.x CrossRefPubMed

49.

Wells ML, Venkatesh SK (2017) Congestive hepatopathy. Abdom Radiol (NY) . https://doi.org/10.1007/s00261-017-1387-x CrossRef

50.

Wells ML, Hough DM, Fidler JL, et al. (2017) Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. Abdom Radiol (NY) 42(11):2623–2631. https://doi.org/10.1007/s00261-017-1181-9 CrossRef

Title: Diagnosis of Budd–Chiari syndrome
Authors: Morgane Van Wettere
Onorina Bruno
Pierre-Emmanuel Rautou
Valérie Vilgrain
Maxime Ronot
Publication date: 01-08-2018
Publisher: Springer US
Published in: Abdominal Radiology / Issue 8/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-017-1447-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2018

Liver vascular anatomy: a refresher

Congenital portosystemic shunts: diagnosis and treatment

‘Stone street’ ureter

The double channel pylorus

Congestive hepatopathy

Benign and malignant hepatocellular lesions in patients with vascular liver diseases

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials